Gonadal failure after treatment of hematologic malignancies: from recognition to management for health-care providers (Q37072348)

18 August 2017

1 reference

title

Gonadal failure after treatment of hematologic malignancies: from recognition to management for health-care providers (English)

1 reference

18 August 2017

4

Richard E Champlin

1 reference

18 August 2017

Kazutaka Nakayama

1

1 reference

18 August 2017

Andrea Milbourne

series ordinal

2

1 reference

18 August 2017

Leslie R Schover

series ordinal

3

1 reference

18 August 2017

Naoto T Ueno

series ordinal

5

1 reference

18 August 2017

1 February 2008

1 reference

Nature Clinical Practice Oncology

18 August 2017

1 reference

18 August 2017

5

1 reference

18 August 2017

78-89

1 reference

18 August 2017

2

1 reference

N-acetylaspartate as an in vivo marker of neuronal viability in kainate-induced status epilepticus: 1H magnetic resonance spectroscopic imaging

18 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

Predicting age of ovarian failure after radiation to a field that includes the ovaries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

Fertility after treatment for cancer. Questions remain over ways of preserving ovarian and testicular tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

Fresh and cryopreserved ovarian tissue samples from donors with lymphoma transmit the cancer to graft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

Use of testosterone to prevent cyclophosphamide-induced azoospermia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

21 January 2018

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Motivation for parenthood after cancer: a review

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Having children after cancer. A pilot survey of survivors' attitudes and experiences

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

American Society of Clinical Oncology recommendations on fertility preservation in cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Discussions regarding reproductive health for young women with breast cancer undergoing chemotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Current methods of the US Preventive Services Task Force: a review of the process

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Maintenance of ovarian function and risk of premature menopause related to cancer treatment

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Ovarian function following marrow transplantation for aplastic anemia or leukemia

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Menstrual cycle, pregnancies and offspring before and after MOPP therapy for Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

The relationship of gonadal activity and chemotherapy-induced gonadal damage

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Imminent ovarian failure in childhood cancer survivors.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Gonadal function in males after chemotherapy for early-stage Hodgkin's lymphoma treated in four subsequent trials by the European Organisation for Research and Treatment of Cancer: EORTC Lymphoma Group and the Groupe d'Etude des Lymphomes de l'Adult

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Gonadal status and reproductive function following treatment for Hodgkin's disease in childhood: the Stanford experience

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Male gonadal dysfunction in patients with Hodgkin's disease prior to treatment

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Semen analysis and cryoconservation before treatment in Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Semen cryopreservation, utilisation and reproductive outcome in men treated for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Cryopreservation of sperm from patients with leukemia: is it worth the effort?

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Semen quality and cryopreservation in adolescent cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Characteristics of cryopreserved semen from men with lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Sperm quality in Hodgkin's disease versus non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Semen analysis in Hodgkin's disease before the onset of treatment

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Semen cryopreservation and artificial insemination for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Dyspermia in men with localized Hodgkin's disease. A potentially reversible, immune-mediated disorder

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

DNA damage in patients with untreated cancer as measured by the sperm chromatin structure assay.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

An evaluation of chromatin condensation and DNA integrity in the spermatozoa of men with cancer before and after therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Late effects on gonadal function of cyclophosphamide, total-body irradiation, and marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

The effects of Hodgkin's disease and combination chemotherapy on gonadal function in the adult male

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVD

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

The effect of combination chemotherapy on ovarian function in women treated for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Long-term reduction in sperm count after chemotherapy with and without radiation therapy for non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Fertility and ovarian function are preserved in women treated with an intensified regimen of cyclophosphamide, adriamycin, vincristine and prednisone (Mega-CHOP) for non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Male fertility in long-term survivors of childhood acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Ovarian function following the treatment of childhood acute lymphoblastic leukaemia.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Late effects of treatment in survivors of childhood acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Acute ovarian failure in the childhood cancer survivor study.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Ovarian function after autologous bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Endocrine complications of high-dose therapy with stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Patterns of Leydig cell insufficiency in adult males following bone marrow transplantation for haematological malignancies

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Recovery of spermatogenesis following bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Prevalence of conception and pregnancy outcomes after hematopoietic cell transplantation: report from the Bone Marrow Transplant Survivor Study.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

The influence of radiation on fertility in man.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Effect of irradiation treatment on gonadal function in men treated for germ cell cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Aspermia following lower truncal irradiation in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Female survivors of childhood cancer: preterm birth and low birth weight among their children.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Impact of cancer treatment on uterine function.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Radiation-induced hypopituitarism is dose-dependent

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Hypothalamic/pituitary function following high-dose conformal radiotherapy to the base of skull: demonstration of a dose-effect relationship using dose-volume histogram analysis

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Treatment of gonadal damage in recipients of allogeneic or autologous transplantation for haematological malignancies

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Late reproductive sequelae following treatment of childhood cancer and options for fertility preservation

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Measuring the impact of chemotherapy on fertility in women with breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Age and the ovarian follicle pool assessed with transvaginal ultrasonography

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Preservation of fertility and ovarian function and minimalization of chemotherapy associated gonadotoxicity and premature ovarian failure: the role of inhibin-A and -B as markers

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Prospective analysis of the relationships between the ovarian follicle cohort and basal FSH concentration, the inhibin response to exogenous FSH and ovarian follicle number at different stages of the normal menstrual cycle and after pituitary down-r

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Müllerian hormone, inhibin B and ovarian ultrasound

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Semen quality and spermatozoal DNA integrity in survivors of childhood cancer: a case-control study.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Fertility after cancer: a prospective review of assisted reproductive outcome with banked semen specimens

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Sperm cryopreservation in oncological patients: a 14-year follow-up study

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Factors associated with disposition of cryopreserved reproductive tissue.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Children born after assisted fertilization have an increased rate of major congenital anomalies

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

A meta-analysis of controlled studies comparing major malformation rates in IVF and ICSI infants with naturally conceived children

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

In vitro fertilization is associated with an increase in major birth defects

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Assisted reproductive technologies and the risk of birth defects--a systematic review

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Sperm from neonatal mammalian testes grafted in mice.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Transplantation of male germ line stem cells restores fertility in infertile mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Clinical potential and putative risks of fertility preservation in children utilizing gonadal tissue or germline stem cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Frozen-thawed embryo transfer: influence of clinical factors on implantation rate and risk of multiple conception

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Assisted reproductive technology in the United States: 1998 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Successful pregnancy after allogeneic bone marrow transplant with embryos isolated before transplant

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Radiotherapy after ovarian transposition: ovarian function and fertility preservation

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Laparoscopic oophoropexy and ovarian function in the treatment of Hodgkin disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Laparoscopic unilateral ovarian transposition prior to irradiation: prospective study of 20 cases

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Efficiency of oocyte cryopreservation: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Outcome of 518 salvage oocyte-cryopreservation cycles performed as a routine procedure in an in vitro fertilization program.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Fertility preservation in female patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Ovarian function preservation in the cancer patient

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Livebirth after orthotopic transplantation of cryopreserved ovarian tissue

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Pregnancy after Transplantation of Cryopreserved Ovarian Tissue in a Patient with Ovarian Failure after Chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Low temperature storage and grafting of human ovarian tissue

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Ovarian transplantation in a series of monozygotic twins discordant for ovarian failure

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Investigation of suppression of the hypothalamic-pituitary-gonadal axis to restore spermatogenesis in azoospermic men treated for childhood cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Oncologists' attitudes and practices regarding banking sperm before cancer treatment.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Sperm cryopreservation before cancer chemotherapy helps in the emotional battle against cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Efficacy of emotion-focused and problem-focused group therapies for women with fertility problems.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Fertility preservation and reproduction in cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1016

7 January 2021

Identifiers

DOI

10.1038/NCPONC1016

1 reference

18 August 2017

1 reference